Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

2.01
Delayed Data
As of Mar 27
 -0.02 / -0.99%
Today’s Change
1.25
Today|||52-Week Range
5.27
+34.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues2.2M1.5M457.0K1.5M
 
 
 
 
 
Cost of Goods Sold3.0M4.1M2.4M4.0M
 
 
 
 
 
Depreciation And Amortization831.0K839.0K846.0K--
 
 
 
 
 
Operating ExpensesGross Income-1.6M-3.4M-2.8M-2.5M
 
 
 
 
 
General Expenses7.2M7.9M7.2M4.8M
 
 
 
 
 
Research And Development3.1M4.0M3.4M3.2M
 
 
 
 
 
Total Operating Expenses11.0M12.8M10.5M8.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.8M-11.3M-10.0M-7.3M
 
 
 
 
 
Extraordinary Credit0.007.6M0.002.8M
 
 
 
Extraordinary Charge-1.2M---1.1M--
 
 
 
Interest Expense On Debt788.0K2.2M2.2M2.2M
 
 
 
 
 
Other Expenses0.000.000.00-9.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.7M-6.0M-13.3M-6.7M
 
 
 
 
 
Net Income-10.7M-6.0M-13.3M-6.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS17.3M17.3M17.4M--
 
 
 
 
Shares To Calculate EPS Diluted17.3M17.3M17.4M--
 
 
 
 
 
Earnings Per ShareEPS-$0.62-$0.34-$0.77-$0.35
 
 
 
 
 
EPS Diluted-$0.62-$0.34-$0.77-$0.35
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account